We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of SEEL yet.

SEEL Hedge Fund Activity: Q1 2025 in Review

0 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q1 2025, worth a combined $0 — down 100% from $4.77K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of SEEL and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was AdvisorShares Investments, exiting entirely with an estimated $4.77K sold.

  • 0 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q1 2025, down from 2 in Q4 2024.
  • Funds reported $0 of Seelos Therapeutics, Inc. Common Stock stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q1 2025 and 2 closed out, a net change of -2 holders.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q1 2025 was AdvisorShares Investments, an estimated $4.77K sold.

Based on aggregated 13F filings for Q1 2025.